News

CRISPRMED24 Exhibitor Quiz Winners

We created a fun quiz with one question about each of the exhibitor booths. The first few delegates to answer all questions correctly won a prize or two!

By: Karen O'Hanlon Cohrt - Apr. 29, 2024
News

CMN Intelligence - The World’s Most Comprehensive Intelligence Platform for CRISPR-Genomic Medicine and Gene-Editing Clinical Development

Providing market intelligence, data infrastructure, analytics, and reporting services for the global gene-editing sector. Read more...

Three lucky delegates won free registration to CRISPRMED25, while one lucky winner also won a pair of silver earrings kindly sponsored by Jordan Kay from Vector Builder.

Ekin Cemre Bayram Tokac, MD - Doctor at Ege University Hospital, Department of Medical Genetics, Turkey (free reg. to CRISPRMED25)

Elif Kubar, MD - Doctor at Ege University Hospital, Department of Medical Genetics, Turkey (free reg. to CRISPRMED25)

Nutsa Burduli, BSc (Hons), MSc - PhD Student at Karolinska Institutet, Sweden (free reg. to CRISPRMED25 plus earrings)

Tags

HashtagArticleHashtagCRISPRMED24HashtagCRISPRMED24 Landing-page

CLINICAL TRIALS
Non-small Cell Lung Cancer, NSCLC, (NCT06097962)
Sponsors:
Base Therapeutics (Shanghai) Co., Ltd.
Indicator
IND Enabling
Phase I
Phase II
Phase III
Gastric Cancer and Colorectal Cancer, CRC, (NCT07166263)
Sponsors:
Base Therapeutics (Shanghai) Co., Ltd.  
Indicator
IND Enabling
Phase I
Phase II
Phase III
Relapsed or Refractory Acute Myeloid Leukemia, AML, (NCT06541444)
Sponsors:
Base Therapeutics (Shanghai) Co., Ltd.
Indicator
IND Enabling
Phase I
Phase II
Phase III
View all clinical trials
close
Search CRISPR Medicine